Latest receivables for BHTG: $1.9M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
BioHiTech Global (BHTG) currently reports a receivables of $1.9M as of September 2021. That compares with $3.3M in the prior-year period — down 43.8% year over year. Use the charts on this page to explore BioHiTech Global's receivables history and peer comparisons.
BioHiTech Global's receivables decreased from $3.3M to $1.9M — a 43.8% year-over-year decrease (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
BioHiTech Global reported $1.9M in receivables as of September 2021. That compares with $3.3M in the prior-year period — down 43.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $1.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioHiTech Global, and consider following BHTG for alerts when major investors trade the stock.
BioHiTech Global is classified in the Utilities sector. On receivables, it currently shows $1.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Utilities are usually more informative than comparing BHTG with unrelated industries.